Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumio Takei

Showing results (51-60 of 55) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 55 results.
The Journal of Experimental Medicine|June 15, 2016
G9a regulates group 2 innate lymphoid cell development by repressing the group 3 innate lymphoid cell programFrann Antignano, Mitchell Braam, Michael R Hughes, et al.
Blood|March 5, 2016
UV-inactivated HSV-1 potently activates NK cell killing of leukemic cellsIsmael Samudio, Katayoun Rezvani, Hila Shaim, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patientsKazunari Sugita, Catherine A Steer, Itziar Martinez-Gonzalez, et al.
Blood Advances|November 2, 2020
Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursorsSamuel B Shin, Bernard C Lo, Maryam Ghaedi, et al.
The Journal of Experimental Medicine|June 18, 2024
Human CD127 negative ILC2s show immunological memoryLaura Mathä, Lisette Krabbendam, Sergio Martinez Høyer, et al.
Pageof 6

Showing results (51-60 of 55) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
The Journal of Experimental Medicine|June 15, 2016
G9a regulates group 2 innate lymphoid cell development by repressing the group 3 innate lymphoid cell programFrann Antignano, Mitchell Braam, Michael R Hughes, et al.
Blood|March 5, 2016
UV-inactivated HSV-1 potently activates NK cell killing of leukemic cellsIsmael Samudio, Katayoun Rezvani, Hila Shaim, et al.
The Journal of Allergy and Clinical Immunology|April 11, 2017
Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patientsKazunari Sugita, Catherine A Steer, Itziar Martinez-Gonzalez, et al.
Blood Advances|November 2, 2020
Abortive γδTCR rearrangements suggest ILC2s are derived from T-cell precursorsSamuel B Shin, Bernard C Lo, Maryam Ghaedi, et al.
The Journal of Experimental Medicine|June 18, 2024
Human CD127 negative ILC2s show immunological memoryLaura Mathä, Lisette Krabbendam, Sergio Martinez Høyer, et al.
Pageof 6